Post-transplant lymphoproliferative disease and other malignancies

E.A.M. Verschuuren

Source: Eur Respir Mon; 2009: 45: 226–237
Journal Issue: Lung Transplantation

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E.A.M. Verschuuren. Post-transplant lymphoproliferative disease and other malignancies. Eur Respir Mon; 2009: 45: 226–237

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lymphoproliferative disease and other malignancies
Source: ERS Course 2016
Year: 2016



The role of EBV DNAemia in the assessment of post-transplant lymphoproliferative disorders (PTLD)
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009

Could LDH monitoring after lung transplantation be used as screening tool for post-transplant lymphoproliferative disorder (PTLD)?
Source: International Congress 2017 – Lung transplant outcomes
Year: 2017

Post-transplant bronchiolitis
Source: Annual Congress 2004 - PG14 - Bronchiolitis in adults
Year: 2004


Pulmonary manifestations of haematological diseases: from lymphoma to sickle cell crisis
Source: International Congress 2018 – Respiratory medicine meets hematology
Year: 2018


Clonality analysis in lymphocytic interstitial pneumonia and other lymphoproliferative disorders in the lung
Source: Eur Respir J 2006; 28: Suppl. 50, 306s
Year: 2006

Sarcoidosis and autoimmune thyroid disease
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012


Pulmonary veno-occlusive disease in myeloproliferative disorder
Source: Eur Respir J 2009; 33: 213-216
Year: 2009



Manifestations of malignancies during the course of sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011

Differential diagnosis of drug-induced toxicity and infectious disorder in haematological malignancies
Source: Annual Congress 2009 - PG7 Drug-induced pulmonary toxicity
Year: 2009

Pulmonary complications in patients with hematologic diseases
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012

Pulmonary hypertension in patients with chronic myeloproliferative disorders
Source: Eur Respir Rev 2015; 24: 400-410
Year: 2015



Medical complications of lung transplantation
Source: Eur Respir J 2004; 23: 334-342
Year: 2004



A rare CNS manifestation of pulmonary Tcell lymphoma
Source: Eur Respir J 2007; 30: Suppl. 51, 99s
Year: 2007

Sixteen years‘ experience of lymphoproliferative disease following lung transplantation
Source: Eur Respir J 2007; 30: Suppl. 51, 174s
Year: 2007

Prevalance of pulmonary hypertension in chronic myeloproliferative diseases
Source: Annual Congress 2011 - Novel clinical features of acute and chronic lung diseases
Year: 2011


Pulmonary graft-versus-host disease (GVHD) post- stem cell transplant (SCT) for haematological malignancies: Good response to treatment if diagnosed early
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012